Analytical Data
-
Gene name
PB000185.00.0
- Application
-
Alternative Names
PB000185.00.0; L-lactate dehydrogenase; EC 1.1.1.27
-
Species
Plasmodium berghei
-
Source
E. coli
-
Tag
N- His & C- Myc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q7SI97
-
Expression Region
1-316aa
-
Molecular Weight
39.4 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PB000185.00.0 is a recombinant protein that has garnered attention in biomedical research due to its potential applications in therapeutic and diagnostic fields. The study of this protein is driven by the need to understand its functional role in cellular processes, particularly in relation to disease states such as cancer and metabolic disorders. Recombinant proteins like PB000185.00.0 are produced using genetic engineering techniques, allowing for large-scale production and purification, which is crucial for various experimental applications. Investigating the structure-function relationship of PB000185.00.0 may reveal insights into its mechanism of action, enabling researchers to design targeted interventions or enhance existing treatment modalities. Moreover, the protein’s characteristics may also aid in the development of more reliable biomarkers for disease diagnosis and prognosis. Overall, the research surrounding PB000185.00.0 is pivotal as it not only contributes to our fundamental understanding of molecular biology but also holds promise for advancing clinical practices and improving patient outcomes.
